IPP Bureau
Cloud adoption helping healthcare providers drive higher levels of patient care
By IPP Bureau - February 01, 2023
91% of cloud leaders expect their cloud capabilities to be largely centralized within the next 2 years and 64% of cloud leaders have realized cybersecurity cost savings by migrating to cloud
Sun Pharma Q3 FY23 Gross Sales up 13.1%; Net profit up 5.2%
By IPP Bureau - February 01, 2023
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
Economic Survey 2022-23: Industry sector witness growth of 4.1%
By IPP Bureau - February 01, 2023
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
By IPP Bureau - January 31, 2023
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
Global diagnostic imaging market to reach $31.9 billion in 2023: GlobalData
By IPP Bureau - January 31, 2023
Diagnostic imaging will become an increasingly vital process in healthcare
Kokilaben Hospital launches Ortho Robot ‘Stryker Mako’
By IPP Bureau - January 31, 2023
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Alkem to launch novel antibiotic for MDR infections
By IPP Bureau - January 31, 2023
Zidavi is recommended by the Infectious Disease Society of America
Aptar Pharma launches highly recyclable nasal spray pump
By IPP Bureau - January 31, 2023
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
FDA approves Keytruda as adjuvant treatment for non-small cell lung cancer
By IPP Bureau - January 30, 2023
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
Briefs: Krsnaa Diagnostics and Solara Active Pharma Sciences
By IPP Bureau - January 30, 2023
Krsnaa Diagnostics Limited has operationalized one diagnostics center at district hospital Male Akbarpur, Kanpur Dehat, Uttar Pradesh.
ExeGi Pharma gets clearance of IND application for EXE-346 a Live biotherapeutic biologic drug
By IPP Bureau - January 30, 2023
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
NIB is playing a vital role in ensuring that quality biological products reach the health system: Dr. Mandaviya
By IPP Bureau - January 29, 2023
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
Glenmark Life Sciences posts Q3 FY23 PAT at Rs. 104.99 Cr
By IPP Bureau - January 29, 2023
The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022
Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr
By IPP Bureau - January 29, 2023
The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022
Aarti Drugs Q3 FY23 revenue grows 4%
By IPP Bureau - January 28, 2023
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
